Prognostic value of downregulated 5-hydroxymethylcytosine expression in renal cell carcinoma: a 10 year follow-up retrospective study.

Chen, Song; Zhou, Qiang; Liu, Tongzu; Zhang, Weibing; Zeng, Xian-Tao; Guo, Zhongqiang

Chen, Song; Zhou, Qiang; Liu, Tongzu; Zhang, Weibing; Zeng, Xian-Tao; Guo, Zhongqiang.

Afiliación

Chen S; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Zhou Q; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Liu T; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Zhang W; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Zeng XT; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Guo Z; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.

J Cancer ; 11(5): 1212-1222, 2020.

Article en En | MEDLINE | ID: mdl-31956367

Palabras clave

5-hydroxymethylcytosine; clinical significance; nomogram.; renal cell carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: J Cancer Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google